Medical technology company Artrya (ASXAYA) has announced a commercial contract with Lumus Imaging for the use of the Salix Coronary Anatomy platform.
Lumus, one of Australia's leading diagnostic imaging providers, operates 150 Imaging centres nationally. Under a 36-month agreement, the Salix Coronary Anatomy platform will first be integrated into Lumus Imaging's centre at St George Private Hospital in Sydney.
Lumus will use Salix to detect critical markers, including high-risk plaque, from CT coronary angiogram (CTCA) scans generated by a Photon Counting CT scanner. Lumus Imaging is one of only two centres in the southern hemisphere equipped with this cutting-edge scanner, regarded as the most advanced CT technology globally.
Artrya CEO Mathew Regan said, “Our contract with Lumus is a significant milestone for our commercial growth in Australia. We are pleased to be partnering with one of Australia's top imaging groups, placing our lifesaving, AI-driven technology in the hands of Australian clinicians to improve the diagnosis of the world’s number one killer, heart disease.
"We are just scratching the surface of the market for domestic diagnostic imaging. Having Salix integrated into a key imaging centre such as St George with a world-leading Photon Scanner provides a significant entry into this important and growing sector in Australia.
“Lumus understands the benefits Salix brings to accurately identify the true markers of heart disease on CTCA images at the point of care, even when using the world’s most advanced CT scanner, the Photon Counting CT. The accuracy of Salix is further enhanced when used to assess images with significantly higher definitions than regular CTCA scans."
Dr Phil Lucas, CEO of Lumus Imaging, added, “We are thrilled to incorporate Salix Coronary Anatomy as part of Lumus Imaging's diagnostic tools for cardiovascular disease. Salix offers an evidence-based, personalised approach to how we diagnose patients at risk of cardiovascular disease. The layer of expertise Salix provides, and particularly when paired with our Photon Counting CT scanner, ensures we continue to be at the cutting edge of heart disease diagnosis."